Abbott Laboratories
Michael F Roman (Director) reports ABT insider transactions
About this filing
Abbott Laboratories (ABT) filed Form 4 (insider transaction) with the SEC on Oct 2, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Michael F Roman · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | A · grantStock Equivalent UnitsFootnotes F1, F2 | +381 | $98.83 | $37,654.23 | 7,166 | Direct |
Footnotes
- F1 Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
- F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
More ABT filings
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Oct 21, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.